MacroGenics Provides Update on Corporate Progress and Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Macrogenics (MGNX) Tops Q3 EPS by 7c
November 6, 2019 5:47 PM ESTMacrogenics (NASDAQ: MGNX) reported Q3 EPS of ($0.91), $0.07 better than the analyst estimate of ($0.98). Revenue for the quarter came in at $18.7 million versus the consensus estimate of $19.12 million.
MacroGenics most advanced programs are positioned to initiate or complete registration-directed studies over the... More
